Role of human milk oligosaccharides in Group B Streptococcus colonisation

Clinical and Translational Immunology

Volumn 5, Issue 8, 2016, Pages

  Andreas, Nicholas J ^a,b   Al Khalidi, Asmaa ^b,c   Jaiteh, Mustapha ^d   Clarke, Edward ^d   Hyde, Matthew J ^b   Modi, Neena ^b   Holmes, Elaine ^b,c   Kampmann, Beate ^a   Doare, Kirsty Mehring Le ^a,e  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Vaccines and Immunity Theme   (Gambia)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85117041523     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/CTI.2016.43     Document Type: Article

References (38)

1. Jones N, Oliver K, Jones Y, Haines A, Crook D. Carriage of group B streptococcus in pregnant women from Oxford, UK. JClinPathol2006; 59: 363–366.
2. Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96: F9–F14.
3. Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev 2014; 27: 21–47.
4. Dangor Z, Lala SG, Cutland CL, Koen A, Jose L, Nakwa F et al. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLos ONE 2015; 10: e0123014.
5. Talbert AW, Mwaniki M, Mwarumba S, Newton CR, Berkley JA. Invasive bacterial infections in neonates and young infants born outside hospital admitted to a rural hospital in Kenya. Pediatr Infect Dis J. 2010; 29: 945–949.
6. Le Doare K, Jarju S, Darboe S, Warburton F, Gorringe A, Heath PT et al. Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants. J Infect 2016; 72: 283–294.
7. Kotiw M, Zhang GW, Daggard G, Reiss-Levy E, Tapsall JW, Numa A. Late-onset and recurrent neonatal Group B streptococcal disease associated with breast-milk transmis-sion. Pediatr Dev Pathol 2003; 6: 251–256.
8. Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases NCfI, Respiratory Diseases CfDC, Prevention. Prevention of perinatal group B streptococcal disease– revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59: 1–36.
9. Hanson LA. Breastfeeding provides passive and likely long-lasting active immunity. Ann Allergy Asthma Immunol 1998; 81: 523–533 (quiz 533–534, 537).
10. Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol 2004; 4: 565–572.
11. Newburg DS. Innate immunity and human milk. JNutr2005; 135: 1308–1312.
12. Victora CG, Bahl R, Barros AJ, Franca GV, Horton S, Krasevec J et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 2016; 387: 475–490.
13. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 2005; 135: 1304–1307.
14. Thurl S, Munzert M, Henker J, Boehm G, Muller-Werner B, Jelinek J et al. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br J Nutr 2010; 104: 1261–1271.
15. Chaturvedi P, Warren CD, Altaye M, Morrow AL, Ruiz-Palacios G, Pickering LK et al. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 2001; 11: 365–372.
16. Zivkovic AM, German JB, Lebrilla CB, Mills DA. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci USA 2011; 108(Suppl 1): 4653–4658.
17. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 731–747.
18. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005; 25: 37–58.
19. Nordgren J, Sharma S, Bucardo F, Nasir W, Gunaydin G, Ouermi D et al. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin Infect Dis 2014; 59: 1567–1573.
20. Payne DC, Currier RL, Staat MA, Sahni LC, Selvarangan R, Halasa NB et al. Epidemiologic association between FUT2 secretor status and severe rotavirus gastro-enteritis in children in the United States. JAMA Pediatr 2015; 169: 1040–1045.
21. Idanpaan-Heikkila I, Simon PM, Zopf D, Vullo T, Cahill P, Sokol K et al. Oligosacchar-ides interfere with the establishment and progression of experimental pneumococcal pneumonia. J Infect Dis 1997; 176: 704–712.
22. LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla CB et al. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem 2007; 55: 8914–8919.
23. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012; 22: 1147–1162.
24. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campy-lobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2 Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. JBiolChem 2003; 278: 14112–14120.
25. Barthelson R, Mobasseri A, Zopf D, Simon P. Adherence of Streptococcus pneumoniae to respiratory epithelial cells is inhibited by sialylated oligosaccharides. Infect Immun 1998; 66: 1439–1444.
26. Bode L. The functional biology of human milk oligosaccharides. Early Hum Dev 2015; 91: 619–622.
27. Weichert S, Jennewein S, Hufner E, Weiss C, Borkowski J, Putze J et al. Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines. Nutr Res 2013; 33: 831–838.
28. Totten SM, Zivkovic AM, Wu S, Ngyuen U, Freeman SL, Ruhaak LR et al. Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. J Proteome Res 2012; 11: 6124–6133.
29. Erney RM, Malone WT, Skelding MB, Marcon AA, Kleman-Leyer KM, O'Ryan ML et al. Variability of human milk neutral oligosaccharides in a diverse population. J Pediatr Gastroenterol Nutr 2000; 30: 181–192.
30. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. JBiolChem1957; 226: 497–509.
31. Andreas NJ, Hyde MJ, Gomez-Romero M, Lopez-Gonzalvez MA, Villasenor A, Wijeyesekera A et al. Multiplatform characterization of dynamic changes in breast milk during lactation. Electrophoresis 2015; 36: 2269–2285.
32. Villasenor A, Garcia-Perez I, Garcia A, Posma JM, Fernandez-Lopez M, Nicholas AJ et al. Breast milk metabolome characterization in a single-phase extraction, multiplatform analytical approach. Anal Chem 2014; 86: 8245–8252.
33. Dona AC, Jimenez B, Schafer H, Humpfer E, Spraul M, Lewis MR et al. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal Chem 2014; 86: 9887–9894.
34. Veselkov KA, Lindon JC, Ebbels TM, Crockford D, Volynkin VV, Holmes E et al. Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. Anal Chem 2009; 81: 56–66.
35. Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem 2006; 78: 4281–4290.
36. 1H NMR data sets. Anal Chem 2005; 77: 1282–1289.
37. Pratico G, Capuani G, Tomassini A, Baldassarre ME, Delfini M, Miccheli A. Exploring human breast milk composition by NMR-based metabolomics. Nat Prod Res 2014; 28: 95–101.
38. Wold S, Esbensen K, Geladi P. Principal component analysis. Chemometr Intell Lab 1987; 2: 37–52.